Clinical Trials
2
Active:1
Completed:1
Trial Phases
2 Phases
Phase 2:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (50.0%)Phase 2
1 (50.0%)Mindfulness for Newly Diagnosed Multiple Sclerosis
Not Applicable
Completed
- Conditions
- Multiple Sclerosis
- First Posted Date
- 2018-07-31
- Last Posted Date
- 2021-03-23
- Lead Sponsor
- Sarah Morrow
- Target Recruit Count
- 26
- Registration Number
- NCT03607773
- Locations
- 🇨🇦
London Health Sciences Center, London, Ontario, Canada
Adderall XR and Cognitive Impairment in MS
- First Posted Date
- 2016-02-08
- Last Posted Date
- 2024-10-17
- Lead Sponsor
- Sarah Morrow
- Target Recruit Count
- 180
- Registration Number
- NCT02676739
- Locations
- 🇨🇦
Kaye Edmonton Clinic, Edmonton, Alberta, Canada
🇨🇦London Health Sciences Centre, London, Ontario, Canada
🇨🇦Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
News
No news found